Silver Creek Pharmaceuticals

About:

Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.

Website: http://www.silvercreekpharma.com

Top Investors: Goldman Sachs, JP Morgan, Absa Bank Kenya

Description:

Silver Creek Pharmaceuticals, a biotechnology company, develops protein therapeutics to treat cardiovascular diseases. The company's mission is to provide smart growth factors to those suffering from organ damage as a result of an acute injury. Scp776 is currently being tested in clinical trials for the treatment of stroke.

Total Funding Amount:

$29.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2010-01-01

Founders:

Ulrik Nielsen

Number of Employees:

11-50

Last Funding Date:

2022-02-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai